Stents, scaffolds and DCB

Latest Stents, scaffolds and DCB content in interventional cardiology - research, practice, and education

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

505 results

Interventional pot pourri #1

19 Dec 2024 – From GulfPCR-GIM 2024

Dive into this 'Interventional potpourri' session for a diverse array of captivating case studies and innovative techniques in interventional cardiology. Explore an anomalous right coronary artery origin, tackle a complex and poorly understood lesion, discover the integration of artificial intelligence in stentless PCI, and master the...

Interventional pot pourri #1

Leave nothing behind - Advancing DCB strategies in complex interventions

18 Dec 2024 – From GulfPCR-GIM 2024

Explore cutting-edge strategies for optimizing drug-coated balloon (DCB) procedures in this session. Uncover practical tips to improve outcomes, review key indications, and examine international consensus on DCB use. Case presentations and expert discussions offer insights to refine your approach.

Leave nothing behind

Best abstracts session #1

18 Dec 2024 – From GulfPCR-GIM 2024

Join us for this dynamic 'Best Abstracts' session, where we delve into the latest research and insights from the world of interventional cardiology. Explore a diverse range of topics, from the use of E/e ratio as a marker for predicting periprocedural myocardial infarction in diabetic patients,...

Best abstracts session #1

Align for the future with Myval THV series and complex PCI solutions

18 Dec 2024 – From GulfPCR-GIM 2024

Explore the future of complex PCI with Meril Life’s advanced solutions. Learn about thin-strut platforms, dedicated stents for side branches and diffuse lesions, the role of drug-eluting balloons in metal-free PCI, and the clinical potential of the Myval THV technology.

Align for the future with Myval THV series and complex PCI solutions

Revolutionising coronary care: the impact of drug-coated balloons in acute and chronic artery disease - A stentless future

18 Dec 2024 – From GulfPCR-GIM 2024

Discover how drug-coated balloons (DCBs) are revolutionizing coronary care, with insights into their use in both acute and chronic artery disease management. Explore the potential for a stentless future as you learn about the role of DCBs in acute coronary events, their impact on chronic artery...

Revolutionising coronary care: the impact of drug-coated balloons in acute and chronic artery disease - A stentless future

Management of coronary aneurysms

18 Dec 2024 – From GulfPCR-GIM 2024

Explore this session to discover innovative approaches to the management of complex coronary aneurysms. From contrast-induced nephropathy prevention using a balloon angiography system to rescue techniques for wire fracture during atherectomy, you'll gain insights into navigating challenging scenarios. Dive deeper into the percutaneous exclusion of a...

Management of coronary aneurysms

Editorial: Focus on Drug-Coated Balloons (DCB) in clinical practice

19 Dec 2024

DCBs have undergone extensive development to meet the challenges of minimizing restenosis and maintaining vessel patency. Unlike stents, DCBs deliver an antiproliferative drug directly to the arterial wall without leaving a permanent implant. This approach has proven effective in treating small-vessel disease, in-stent restenosis, and de...

Prof. Andreas Baumbach

Author

Andreas Baumbach
Focus on DCBs: Editorial from Andreas Baumbach

A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions

05 Dec 2024

The present study compares a novel sirolimus-coated balloon with a clinically proven paclitaxel-coated balloon for the treatment of de novo coronary lesions, demonstrating non-inferiority in terms of angiographic late lumen loss at 6 months.

Mauro Gitto

Reviewer

Mauro Gitto
Nicola Ryan

Reviewer

Nicola Ryan
A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions

“BIO-PCI” the turning point of vascular interventions?

03 Dec 2024

Discuss the rationale of a PCI strategy with minimal metal as a turning point of vascular interventions with Flavio Luciano Ribichini, Salvatore Brugaletta and Piera Capranzano.

“BIO-PCI” the turning point of vascular interventions?

Let it heal!

05 Feb 2025

The purpose of this case report is to discuss the treatment of a chronic total occlusion (CTO) in a 58-year-old male patient with multiple cardiovascular risk factors including type 2 diabetes, dyslipidemia, hypertension, and smoking history.

Angio showed a CTO of the RCA. In the MR-Scan, the RCA...

Johannes Rigger

Author

Johannes Rigger
Let it heal!